The best of R&I and around the web, handpicked by our editors.
White papers, service directory and conferences for the R&I community.
Web replica of the print magazine.
A look at the latest decisions impacting the industry.
The use of wood framing in mid-size residential construction raises concerns
Disruptive innovation is unfolding in the form of alternative workers’ comp systems.
Risk managers must be prepared for SEC regulators, cyber-related lawsuits and other new litigation trends.
A risk management professional constructed a versatile system that he can really believe in.
When a driver crashes under mysterious circumstances, an adjuster turns sleuth to suss out the truth.
Nurse case managers can provide vital consultation, but contractual limits to the expenses associated with the service are advisable.
Three executives are accused of taking proprietary information with them when they joined a rival firm.
Risk managers should review policies to ensure they provide cover for risks associated with treating a patient presenting Ebola symptoms.
Risk managers must increase awareness of red flags indicating international fraud schemes.
The Affordable Care Act has resulted in higher plan costs and more employers shifting costs to workers.
While there has been much research and planning regarding the environmental aspects of climate change, few are discussing the potential impact on workers.
OSHA is considering reducing the burden of proof to find merit in a whistleblower’s claims.
To meet the challenges of the future, organizations must focus on education.
Companies must assess the risks of vendors that provide critical operations or have access to customer information.
Though risk to US health care workers remains low, an Ebola outbreak could pose a workers’ comp risk to the industry.
The legacy of Joan Rivers could be a more open, honest discussion about medical outcomes.
Local governments must be open and accessible. They also have the highest rates of injuries.
Physicians and advocacy groups are taking a stand against the FDA’s approval of a new extended release opioid.
Network exposures can add up to big losses for companies.
Newsletters
Risk Central
Risk Central
Digital Edition
